Muslim L. Alabdullah
Nottingham, ENG NG51PB, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers.
Journal: Biomedicines
Published: December 07, 2020
RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers.
Journal: Molecular biomedicine
Published: November 26, 2020
Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.
Journal: Theranostics
Published: August 03, 2020
ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity.
Journal: Cells
Published: September 24, 2019
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.
Journal: Cancer letters
Published: August 01, 2019
The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: February 05, 2019
ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers.
Journal: Gynecologic oncology
Published: October 08, 2018
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers.
Journal: Breast cancer research and treatment
Published: August 24, 2016
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.
Journal: Breast cancer research and treatment
Published: February 06, 2015
ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer.
Journal: Breast cancer research and treatment
Published: June 05, 2014
Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer.
Journal: Breast cancer research and treatment
Published: January 16, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026